MYXOFIBROSARCOMA (MFS)
Clinical trials for MYXOFIBROSARCOMA (MFS) explained in plain language.
Never miss a new study
Get alerted when new MYXOFIBROSARCOMA (MFS) trials appear
Sign up with your email to follow new studies for MYXOFIBROSARCOMA (MFS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called OKN4395, alone or with an immunotherapy (pembrolizumab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe doses and see if the drug can shrink tumors. About 166…
Matched conditions: MYXOFIBROSARCOMA (MFS)
Phase: PHASE1 • Sponsor: Epkin • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New 3-Week radiation plan aims to cut side effects for sarcoma patients
Disease control Recruiting nowThis study tests whether a personalized, 3-week course of proton or x-ray radiation before surgery can reduce long-term side effects for adults with soft tissue sarcoma. About 110 participants will have two radiation plans made, and a national team will choose the best one for ea…
Matched conditions: MYXOFIBROSARCOMA (MFS)
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 08, 2026 12:04 UTC